Huahai Pharmaceutical announced that the company held the 14th interim meeting of the 9th board of directors on July 15, 2026 to review and approve the appointment of Xu Xuejian as the company's vice president and chief quality officer, who is fully responsible for the company's quality management, analysis and testing work. The term of office is until the end of the 9th board of directors. Xu Xuejian has worked for companies such as Jiangsu Hengrui Pharmaceutical. Up to now, he has not held shares in the company, has no relationships with relevant parties in the company, and is eligible for employment.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.